← 產業報告目錄

Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-05-13頁數 245報告編號 MD9362

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0% during the forecast period. The global market for dental anesthetics is expanding due to a rising incidence of dental issues, which has led to an increase in dental procedures. Furthermore, there is greater awareness of the importance of oral health and cosmetic dentistry, prompting more individuals to seek dental treatments. Improved income levels and enhanced healthcare infrastructure in many regions make dental care more accessible. Additionally, the growing elderly population is expected to drive up demand for these services. However, during the projected period, challenges such as a shortage of dental practitioners and limited insurance coverage for dental procedures may hinder market growth to some extent. “Articaine is expected to grow at the highest CAGR during the forecast period.” Articaine is projected to experience the highest CAGR during the forecast period due to its numerous advantages over other types of anesthetics. Unlike other amide anesthetics that contain a benzene ring, articaine features a thiophene ring, which leads to increased lipid solubility and improved penetration into tissues and nerve membranes. This enhanced diffusion through both hard and soft tissues makes articaine particularly effective for mandibular infiltrations, where nerve blocks are often required with other anesthetics. Consequently, dentists find that articaine performs better in areas with dense bone structures. Additionally, various studies have confirmed its safety profile when used appropriately, even among elderly and pediatric patient populations. These advantages contribute to the growing popularity of articaine and support its market expansion. “The topical anesthetics segment is expected to grow at the highest CAGR in the dental anesthetics market, by route of administration.” The topical anesthetics market is projected to experience the highest growth in the dental anesthetics market, driven by their widespread use in standard procedures, ease of application, non-invasiveness, and ability to provide quick surface anesthesia. Dentists increasingly utilize new technologies such as gels, metered-dose sprays, and patches. Additionally, the introduction of needle-free anesthesia and the availability of topical anesthetics in various flavors contribute to their increased adoption. Although topical anesthetics are limited by their short duration of action, their reliability and broad range of applications continue to fuel market growth. “Based on end users, the dental clinics segment is expected to dominate the dental anesthetics market during the forecast period.” The demand for dental anesthetics is primarily driven by the growth of dental clinics in developing regions of Latin America and the Asia Pacific. As dental services become more accessible in countries such as Vietnam, Indonesia, and India, a greater number of patients are seeking surgeries that require effective pain management. Key factors contributing to the expansion of dental clinics include rising incomes among the middle class, urbanization, and an increasing awareness of oral health. Consequently, there is a growing need for reliable topical and local anesthetics, as more dental clinics now offer restorative and cosmetic procedures. “The Asia Pacific is expected to register the highest CAGR in the dental anesthetics market during the forecast period.” The dental anesthetics market in the Asia Pacific region is expected to grow at the highest CAGR due to several factors that reflect the changing landscape of healthcare. The rising prevalence of dental infections and greater awareness of oral health drive the demand for dental procedures. Additionally, the region's large and aging population significantly contributes to increased healthcare spending, which boosts the need for easily accessible and patient-friendly treatment options. Improvements in healthcare infrastructure, higher disposable incomes, and advancements in dental anesthetics will also likely fuel growth in the Asia Pacific dental anesthetics market. A summary of the main supply-side participants in the dental anesthetics market is provided below for this report: • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%) • By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%) • By Region: North America (25%), Europe (23%), Asia Pacific (28%), Latin America (17%), Middle East & Africa (7%) The prominent players in the global dental anesthetics market are Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Indústria e Comércio S/A (Brazil), Ultradent Products Inc. (US), Hikma Pharmaceuticals Plc (UK), Clarben Laboratories (Spain), New Stetic S.A (Colombia), Primex Pharmaceuticals (Switzerland), Keystone Industries (US), Centrix, Inc. (US), GC SHOWAYAKUHIN CORPORATION (Japan), DMG America LLC (US), Zeyco (Mexico), Zymeth Pharmaceutical (India), Cetylite, Inc. (US), ICPA Health Products Limited (India), Crosstex International, Inc. (US), Young Innovations, Inc. (US), Mark3 (Cargus International, Inc.) (US), J.Morita Corp. (Japan), Kulzer GmbH (Germany), and Integra Lifesciences Corporation (US). Research Coverage The market study focuses on the dental anesthetics market across various segments. Its purpose is to estimate the market size and growth potential across different categories, including drug type, route of administration, end user, and geographic region. Additionally, the study includes a comprehensive competitive analysis of the key players in the market, along with their company profiles. This analysis features important observations regarding their product offerings, recent developments, and key strategies in the market. Reasons to Buy the Report The report provides valuable information for market leaders and new entrants in the dental anesthetics market, offering approximate revenue figures for both the overall market and its subsegments. It enables stakeholders to understand the competitive landscape, which can help them better position their businesses and develop effective go-to-market strategies. Additionally, the report offers insights into the current state of the market, including critical drivers, restraints, challenges, and opportunities. This report provides insights on the following pointers:  Analysis of key drivers (increasing patient pool for dental treatments, increasing demand for advanced cosmetic dental procedures, and technological advancements in anesthetic delivery), restraints (potential adverse effects), opportunities (rising number of DSOs and growing private equity investments, emerging markets, and growing dental tourism) and challenges (dearth of trained dental practitioners and needle phobia). • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global dental anesthetics market. The report analyzes this market by drug type, route of administration, end user, and region. • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global dental anesthetics market. • Market Development: Thorough knowledge and analysis of the profitable rising markets by drug type, route of administration, end user, and region. • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global dental anesthetics market.
目錄 Table of Contents
1 INTRODUCTION 23 1.1 STUDY OBJECTIVES 23 1.2 MARKET DEFINITION 23 1.3 STUDY SCOPE 24 1.3.1 MARKETS COVERED & REGIONAL SCOPE 24 1.3.2 INCLUSIONS & EXCLUSIONS 25 1.3.3 YEARS CONSIDERED 25 1.4 CURRENCY CONSIDERED 26 1.5 UNIT CONSIDERED 26 1.6 STAKEHOLDERS 26 2 RESEARCH METHODOLOGY 27 2.1 RESEARCH DATA 27 2.1.1 SECONDARY DATA 28 2.1.1.1 Key data from secondary sources 29 2.1.2 PRIMARY DATA 30 2.1.2.1 Key data from primary sources 31 2.1.2.2 Key industry insights 32 2.2 MARKET SIZE ESTIMATION 34 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 39 2.4 MARKET SHARE ESTIMATION 41 2.5 STUDY ASSUMPTIONS 41 2.6 RESEARCH LIMITATIONS 41 2.6.1 SCOPE-RELATED LIMITATIONS 41 2.6.2 METHODOLOGY-RELATED LIMITATIONS 41 2.7 RISK ASSESSMENT 42 3 EXECUTIVE SUMMARY 43 4 PREMIUM INSIGHTS 46 4.1 DENTAL ANESTHETICS MARKET OVERVIEW 46 4.2 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2024) 47 4.3 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48 4.4 DENTAL ANESTHETICS MARKET: REGIONAL MIX 48 4.5 DENTAL ANESTHETICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 49   5 MARKET OVERVIEW 50 5.1 INTRODUCTION 50 5.2 MARKET DYNAMICS 51 5.2.1 DRIVERS 51 5.2.1.1 Increasing patient pool for dental treatments 51 5.2.1.1.1 Dental caries and other dental disorders 51 5.2.1.1.2 Geriatric population and edentulism 52 5.2.1.1.3 Periodontal diseases 53 5.2.1.1.4 Changing lifestyles and unhealthy food habits 54 5.2.1.2 Increasing demand for advanced cosmetic dental procedures 54 5.2.1.3 Technological advancements in anesthetic delivery 55 5.2.2 RESTRAINTS 55 5.2.2.1 Potential adverse effects 55 5.2.3 OPPORTUNITIES 56 5.2.3.1 Rising number of DSOs and growing private equity investments 56 5.2.3.2 Emerging markets 58 5.2.3.3 Growing dental tourism 58 5.2.4 CHALLENGES 59 5.2.4.1 Dearth of trained dental practitioners 59 5.2.4.2 Needle phobia 59 5.3 PORTER’S FIVE FORCES ANALYSIS 60 5.3.1 INTENSITY OF COMPETITIVE RIVALRY 61 5.3.2 BARGAINING POWER OF SUPPLIERS 61 5.3.3 BARGAINING POWER OF BUYERS 61 5.3.4 THREAT OF SUBSTITUTES 61 5.3.5 THREAT OF NEW ENTRANTS 62 5.4 REGULATORY ANALYSIS 62 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 5.4.2 REGULATORY LANDSCAPE 65 5.5 INDUSTRY TRENDS 66 5.5.1 METERED SPRAY SYSTEMS 66 5.5.2 JET INJECTION SYSTEMS 66 5.6 REIMBURSEMENT SCENARIO 66 5.7 TECHNOLOGY ANALYSIS 67 5.7.1 KEY TECHNOLOGIES 67 5.7.1.1 Vasoconstrictors 67 5.7.1.2 Buffering agents 67 5.7.2 COMPLEMENTARY TECHNOLOGIES 68 5.7.2.1 Computer-controlled local anesthetic delivery (CCLAD) systems 68 5.7.3 ADJACENT TECHNOLOGIES 68 5.7.3.1 Reversal agents 68 5.8 KEY CONFERENCES & EVENTS, 2025–2026 69 5.9 PRICING ANALYSIS 70 5.9.1 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION 70 5.9.2 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER 70 5.10 TRADE ANALYSIS 71 5.10.1 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024 72 5.10.2 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024 72 5.11 PATENT ANALYSIS 73 5.11.1 PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS 73 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET 73 5.12 VALUE CHAIN ANALYSIS 76 5.13 ECOSYSTEM ANALYSIS 77 5.14 SUPPLY CHAIN ANALYSIS 78 5.15 CASE STUDY ANALYSIS 80 5.15.1 CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY 80 5.15.2 CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA 80 5.15.3 CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES 81 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81 5.17 KEY STAKEHOLDERS & BUYING CRITERIA 82 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 82 5.17.2 BUYING CRITERIA 83 5.18 ADJACENT MARKET ANALYSIS 84 5.19 UNMET NEEDS/END-USER EXPECTATIONS 84 5.20 IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET 86 5.21 IMPACT OF 2025 US TARIFF – OVERVIEW 86 5.21.1 INTRODUCTION 86 5.21.2 KEY TARIFF RATES 87 5.21.3 PRICE IMPACT ANALYSIS 88 5.21.4 IMPACT ON END-USER INDUSTRIES 88 6 DENTAL ANESTHETICS MARKET, BY DRUG TYPE 89 6.1 INTRODUCTION 90 6.2 LIDOCAINE 92 6.2.1 RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET 92 6.3 MEPIVACAINE 94 6.3.1 UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET 94 6.4 ARTICAINE 96 6.4.1 IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET 96 6.5 BUPIVACAINE 98 6.5.1 PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH 98 6.6 PRILOCAINE 100 6.6.1 LOWER TOXICITY PROFILE TO FUEL UPTAKE 100 6.7 OTHER DRUG TYPES 101 7 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION 103 7.1 INTRODUCTION 104 7.2 TOPICAL ANESTHETICS 106 7.2.1 GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND 106 7.3 INJECTABLE ANESTHETICS 108 7.3.1 HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET 108 7.4 SYRINGES 110 7.4.1 ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET 110 7.5 NEEDLES 112 7.5.1 RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH 112 8 DENTAL ANESTHETICS MARKET, BY END USER 114 8.1 INTRODUCTION 115 8.2 HOSPITALS 115 8.2.1 ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET 115 8.3 DENTAL CLINICS 117 8.3.1 RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET 117 8.4 OTHER END USERS 119 9 DENTAL ANESTHETICS MARKET, BY REGION 121 9.1 INTRODUCTION 122 9.2 EUROPE 124 9.2.1 MACROECONOMIC OUTLOOK FOR EUROPE 124 9.2.2 GERMANY 127 9.2.2.1 Favorable government policies for reimbursement to expedite growth 127 9.2.3 ITALY 130 9.2.3.1 Rising adoption of digital dentistry techniques to augment growth 130 9.2.4 SPAIN 132 9.2.4.1 Presence of well-established dental healthcare infrastructure to foster growth 132 9.2.5 FRANCE 134 9.2.5.1 Favorable distribution network and reimbursement scenario to aid growth 134 9.2.6 UK 136 9.2.6.1 Booming geriatric population to stimulate growth 136 9.2.7 REST OF EUROPE 138 9.3 NORTH AMERICA 139 9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 140 9.3.2 US 143 9.3.2.1 High per capita income and quality of treatment to support growth 143 9.3.3 CANADA 144 9.3.3.1 Rising healthcare expenditure to sustain growth 144 9.4 ASIA PACIFIC 146 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 147 9.4.2 SOUTH KOREA 150 9.4.2.1 Growing elderly population to fuel market 150 9.4.3 JAPAN 153 9.4.3.1 Surge in age-related dental issues to promote growth 153 9.4.4 CHINA 155 9.4.4.1 Shift in demographic trend to accelerate growth 155 9.4.5 INDIA 157 9.4.5.1 Growing cosmetic dentistry sector to fuel market 157 9.4.6 AUSTRALIA 159 9.4.6.1 Increasing access to dental services to favor growth 159 9.4.7 REST OF ASIA PACIFIC 160 9.5 LATIN AMERICA 162 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 162 9.5.2 BRAZIL 164 9.5.2.1 Booming dental tourism to contribute to growth 164 9.5.3 ARGENTINA 166 9.5.3.1 Growing focus on oral health to propel market 166 9.5.4 MEXICO 168 9.5.4.1 Affordable dental care costs to amplify growth 168 9.5.5 REST OF LATIN AMERICA 170 9.6 MIDDLE EAST & AFRICA 171 9.6.1 GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET 171 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 171 9.7 GCC COUNTRIES 173 9.7.1 INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET 173 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 173   10 COMPETITIVE LANDSCAPE 176 10.1 INTRODUCTION 176 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 176 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET 177 10.3 MARKET SHARE ANALYSIS 178 10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 180 10.4.1 STARS 180 10.4.2 EMERGING LEADERS 180 10.4.3 PERVASIVE PLAYERS 181 10.4.4 PARTICIPANTS 181 10.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 182 10.4.5.1 Company footprint 182 10.4.5.2 Region footprint 183 10.4.5.3 Drug type footprint 184 10.4.5.4 Route of administration footprint 185 10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 186 10.5.1 PROGRESSIVE COMPANIES 186 10.5.2 RESPONSIVE COMPANIES 186 10.5.3 DYNAMIC COMPANIES 186 10.5.4 STARTING BLOCKS 186 10.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 188 10.5.5.1 Detailed list of key startups/SMEs 188 10.5.5.2 Competitive benchmarking of key startups/SMEs 188 10.6 COMPANY VALUATION & FINANCIAL METRICS 189 10.6.1 FINANCIAL METRICS 189 10.6.2 COMPANY VALUATION 189 10.7 BRAND/PRODUCT COMPARISON 190 10.8 COMPETITIVE SCENARIO 191 10.8.1 PRODUCT LAUNCHES 191 10.8.2 DEALS 191 10.8.3 EXPANSIONS 192 10.8.4 OTHER DEVELOPMENTS 192 11 COMPANY PROFILES 193 11.1 KEY PLAYERS 193 11.1.1 SEPTODONT HOLDING 193 11.1.1.1 Business overview 193 11.1.1.2 Products/Services/Solutions offered 194 11.1.1.3 Recent developments 195 11.1.1.3.1 Product launches 195 11.1.1.3.2 Deals 195 11.1.1.3.3 Expansions 196 11.1.1.4 MnM view 196 11.1.1.4.1 Right to win 196 11.1.1.4.2 Strategic choices 197 11.1.1.4.3 Weaknesses & competitive threats 197 11.1.2 DENTSPLY SIRONA 198 11.1.2.1 Business overview 198 11.1.2.2 Products/Services/Solutions offered 199 11.1.2.3 Recent developments 200 11.1.2.3.1 Deals 200 11.1.2.4 MnM view 201 11.1.2.4.1 Right to win 201 11.1.2.4.2 Strategic choices 201 11.1.2.4.3 Weaknesses & competitive threats 201 11.1.3 PIERREL 202 11.1.3.1 Business overview 202 11.1.3.2 Products/Services/Solutions offered 202 11.1.3.3 Recent developments 203 11.1.3.3.1 Product launches 203 11.1.3.3.2 Deals 203 11.1.3.4 MnM view 204 11.1.3.4.1 Right to win 204 11.1.3.4.2 Strategic choices 204 11.1.3.4.3 Weaknesses & competitive threats 204 11.1.4 HUONS GLOBAL 205 11.1.4.1 Business overview 205 11.1.4.2 Products/Services/Solutions offered 206 11.1.4.3 Recent developments 207 11.1.4.3.1 Expansions 207 11.1.4.3.2 Other developments 207 11.1.4.4 MnM view 207 11.1.4.4.1 Right to win 207 11.1.4.4.2 Strategic choices 207 11.1.4.4.3 Weaknesses & competitive threats 208 11.1.5 NORMON 209 11.1.5.1 Business overview 209 11.1.5.2 Products/Services/Solutions offered 209 11.1.5.3 MnM view 210 11.1.5.3.1 Right to win 210 11.1.5.3.2 Strategic choices 210 11.1.5.3.3 Weaknesses & competitive threats 211   11.1.6 DFL INDÚSTRIA E COMÉRCIO S/A 212 11.1.6.1 Business overview 212 11.1.6.2 Products/Services/Solutions offered 212 11.1.7 ULTRADENT PRODUCTS INC. 213 11.1.7.1 Business overview 213 11.1.7.2 Products/Services/Solutions offered 213 11.1.7.3 Recent developments 214 11.1.7.3.1 Deals 214 11.1.7.3.2 Expansions 214 11.1.7.3.3 Other developments 214 11.1.8 PRIMEX PHARMACEUTICALS 215 11.1.8.1 Business overview 215 11.1.8.2 Products/Services/Solutions offered 215 11.1.9 KEYSTONE INDUSTRIES 216 11.1.9.1 Business overview 216 11.1.9.2 Products/Services/Solutions offered 216 11.1.10 CLARBEN LABORATORIES 217 11.1.10.1 Business overview 217 11.1.10.2 Products/Services/Solutions offered 218 11.1.11 HIKMA PHARMACEUTICALS PLC 219 11.1.11.1 Business overview 219 11.1.11.2 Products/Services/Solutions offered 220 11.1.12 ZEYCO 221 11.1.12.1 Business overview 221 11.1.12.2 Products/Services/Solutions offered 222 11.1.13 NEW STETIC S.A. 223 11.1.13.1 Business overview 223 11.1.13.2 Products/Services/Solutions offered 224 11.1.14 CETYLITE, INC. 225 11.1.14.1 Business overview 225 11.1.14.2 Products/Services/Solutions offered 225 11.1.15 ICPA HEALTH PRODUCTS LIMITED 226 11.1.15.1 Business overview 226 11.1.15.2 Products/Services/Solutions offered 226 11.2 OTHER PLAYERS 227 11.2.1 CENTRIX, INC. 227 11.2.2 ZYMETH PHARMACEUTICAL 228 11.2.3 DMG AMERICA LLC 229 11.2.4 GC SHOWAYAKUHIN CORPORATION 230 11.2.5 YOUNG INNOVATIONS, INC. 231 11.2.6 CROSSTEX INTERNATIONAL, INC. 232 11.2.7 MARK3 (CARGUS INTERNATIONAL, INC.) 233 11.2.8 J. MORITA CORP. 234 11.2.9 KULZER GMBH 235 11.2.10 INTEGRA LIFESCIENCES CORPORATION 236 12 APPENDIX 237 12.1 DISCUSSION GUIDE 237 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 241 12.3 CUSTOMIZATION OPTIONS 243 12.4 RELATED REPORTS 243 12.5 AUTHOR DETAILS 244
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 26 TABLE 2 DENTAL ANESTHETICS MARKET: RISK ASSESSMENT ANALYSIS 42 TABLE 3 PROJECTED INCREASE IN NUMBER OF PEOPLE AGED OVER 65 YEARS, BY REGION, 2019 VS. 2050 (MILLION) 53 TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY SERVICES, 2021 VS. 2022 55 TABLE 5 US: RECENT DEALS BACKED BY PRIVATE EQUITY, 2020–2024 56 TABLE 6 AVERAGE PROCEDURAL COST IN TOP TEN DENTAL TOURISM DESTINATIONS (USD) 59 TABLE 7 DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 60 TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63 TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 13 DENTAL ANESTHETICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026 69 TABLE 14 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION, 2023–2025 (USD) 70 TABLE 15 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER, 2024 70 TABLE 16 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), BY COUNTRY, 2020–2024 (USD THOUSAND) 72 TABLE 17 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), BY COUNTRY, 2020–2024 (USD THOUSAND) 72 TABLE 18 LIST OF PATENTS IN DENTAL ANESTHETICS MARKET (2022−2024) 75 TABLE 19 DENTAL ANESTHETICS MARKET: ROLE IN ECOSYSTEM 78 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 83 TABLE 21 KEY BUYING CRITERIA FOR END USERS 83 TABLE 22 DENTAL ANESTHETICS MARKET: UNMET NEEDS 84 TABLE 23 DENTAL ANESTHETICS MARKET: END-USER EXPECTATIONS 85 TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 87 TABLE 25 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR DENTAL PRODUCTS 88 TABLE 26 DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 90 TABLE 27 DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 91 TABLE 28 DENTAL ANESTHETICS MARKET FOR LIDOCAINE, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 29 DENTAL ANESTHETICS MARKET FOR MEPIVACAINE, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 30 DENTAL ANESTHETICS MARKET FOR ARTICAINE, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 31 DENTAL ANESTHETICS MARKET FOR BUPIVACAINE, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 32 DENTAL ANESTHETICS MARKET FOR PRILOCAINE, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 33 DENTAL ANESTHETICS MARKET FOR OTHER DRUG TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 34 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 104 TABLE 35 DENTAL ANESTHETICS MARKET FOR ROUTE OF ADMINISTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 36 TOPICAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 37 INJECTABLE ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 38 INJECTABLE ANESTHETICS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 110 TABLE 39 SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 40 NEEDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 41 DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 115 TABLE 42 DENTAL ANESTHETICS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 43 DENTAL ANESTHETICS MARKET FOR DENTAL CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 44 DENTAL ANESTHETICS MARKET FOR OTHER END USERS, BY COUNTRY 2023–2030 (USD MILLION) 120 TABLE 45 DENTAL ANESTHETICS MARKET, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 46 EUROPE: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 47 EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 126 TABLE 48 EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 127 TABLE 49 EUROPE: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 50 GERMANY: DENTIST POPULATION, 2019–2022 128 TABLE 51 GERMANY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 128 TABLE 52 GERMANY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 129 TABLE 53 GERMANY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 129 TABLE 54 GERMANY: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 55 ITALY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 130 TABLE 56 ITALY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 131 TABLE 57 ITALY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 131 TABLE 58 ITALY: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 131 TABLE 59 SPAIN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 132 TABLE 60 SPAIN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 133 TABLE 61 SPAIN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 133 TABLE 62 SPAIN: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 133 TABLE 63 FRANCE: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 134 TABLE 64 FRANCE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 135 TABLE 65 FRANCE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 135 TABLE 66 FRANCE: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 135 TABLE 67 UK: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 136 TABLE 68 UK: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 137 TABLE 69 UK: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 137 TABLE 70 UK: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 71 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 138 TABLE 72 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 139 TABLE 73 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 74 US: DENTAL EXPENDITURE, 2014–2023 (USD BILLION) 140 TABLE 75 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 76 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 142 TABLE 77 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 142 TABLE 78 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 142 TABLE 79 US: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 143 TABLE 80 US: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 144 TABLE 81 US: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 82 CANADA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 145 TABLE 83 CANADA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 145 TABLE 84 CANADA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 146 TABLE 85 CANADA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 146 TABLE 86 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 87 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 149 TABLE 88 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 150 TABLE 89 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 90 SOUTH KOREA: FOREIGN PATIENTS VISITING DENTAL FACILITIES, 2017–2021 151 TABLE 91 SOUTH KOREA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 151 TABLE 92 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 152 TABLE 93 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 152 TABLE 94 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 95 JAPAN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 153 TABLE 96 JAPAN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 154 TABLE 97 JAPAN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 154 TABLE 98 JAPAN: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 99 CHINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 155 TABLE 100 CHINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 156 TABLE 101 CHINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 156 TABLE 102 CHINA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 103 INDIA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 157 TABLE 104 INDIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 158 TABLE 105 INDIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 158 TABLE 106 INDIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 107 AUSTRALIA: MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 159 TABLE 108 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 159 TABLE 109 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 160 TABLE 110 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 111 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 161 TABLE 112 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 161 TABLE 113 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 114 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 115 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 163 TABLE 116 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 164 TABLE 117 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 118 BRAZIL: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 165 TABLE 119 BRAZIL: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 165 TABLE 120 BRAZIL: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 165 TABLE 121 BRAZIL: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 122 ARGENTINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 166 TABLE 123 ARGENTINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 167 TABLE 124 ARGENTINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 167 TABLE 125 ARGENTINA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 126 MEXICO: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET 168 TABLE 127 MEXICO: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 169 TABLE 128 MEXICO: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 169 TABLE 129 MEXICO: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 130 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 170 TABLE 131 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 170 TABLE 132 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 133 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION) 172 TABLE 134 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 172 TABLE 135 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 136 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023– 2030 (USD MILLION) 174 TABLE 137 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 174 TABLE 138 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 139 STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL ANESTHETICS MARKET, JANUARY 2021–MARCH 2025 177 TABLE 140 DENTAL ANESTHETICS MARKET: DEGREE OF COMPETITION 179 TABLE 141 DENTAL ANESTHETICS MARKET: REGION FOOTPRINT 183 TABLE 142 DENTAL ANESTHETICS MARKET: DRUG TYPE FOOTPRINT 184 TABLE 143 DENTAL ANESTHETICS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT 185 TABLE 144 DENTAL ANESTHETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 188 TABLE 145 DENTAL ANESTHETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 188 TABLE 146 DENTAL ANESTHETICS MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 191 TABLE 147 DENTAL ANESTHETICS MARKET: DEALS, JANUARY 2021–MARCH 2025 191 TABLE 148 DENTAL ANESTHETICS MARKET: EXPANSIONS, JANUARY 2021–MARCH 2025 192 TABLE 149 DENTAL ANESTHETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 192 TABLE 150 SEPTODONT HOLDING: COMPANY OVERVIEW 193 TABLE 151 SEPTODONT HOLDING: PRODUCTS/SERVICES/SOLUTIONS OFFERED 194 TABLE 152 SEPTODONT HOLDING: PRODUCTS LAUNCHES, JANUARY 2021–MARCH 2025 195 TABLE 153 SEPTODONT HOLDING: DEALS, JANUARY 2021–MARCH 2025 195 TABLE 154 SEPTODONT HOLDING: EXPANSIONS, JANUARY 2021–MARCH 2025 196 TABLE 155 DENTSPLY SIRONA: COMPANY OVERVIEW 198 TABLE 156 DENTSPLY SIRONA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 199 TABLE 157 DENTSPLY SIRONA: DEALS, JANUARY 2021–MARCH 2025 200 TABLE 158 PIERREL: COMPANY OVERVIEW 202 TABLE 159 PIERREL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 202 TABLE 160 PIERREL: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 203 TABLE 161 PIERREL: DEALS, JANUARY 2021–MARCH 2025 203 TABLE 162 HUONS GLOBAL: COMPANY OVERVIEW 205 TABLE 163 HUONS GLOBAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 206 TABLE 164 HUONS GLOBAL: EXPANSIONS, JANUARY 2021–MARCH 2025 207 TABLE 165 HUONS GLOBAL: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 207 TABLE 166 NORMON: COMPANY OVERVIEW 209 TABLE 167 NORMON: PRODUCTS/SERVICES/SOLUTIONS OFFERED 209 TABLE 168 DFL INDÚSTRIA E COMÉRCIO S/A: COMPANY OVERVIEW 212 TABLE 169 DFL INDÚSTRIA E COMÉRCIO S/A: PRODUCTS/SERVICES/SOLUTIONS OFFERED 212 TABLE 170 ULTRADENT PRODUCTS INC.: COMPANY OVERVIEW 213 TABLE 171 ULTRADENT PRODUCTS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 213 TABLE 172 ULTRADENT PRODUCTS INC.: DEALS, JANUARY 2021–MARCH 2025 214 TABLE 173 ULTRADENT PRODUCTS INC.: EXPANSIONS, JANUARY 2021–MARCH 2025 214 TABLE 174 ULTRADENT PRODUCTS INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 214 TABLE 175 PRIMEX PHARMACEUTICALS: COMPANY OVERVIEW 215 TABLE 176 PRIMEX PHARMACEUTICALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 215 TABLE 177 KEYSTONE INDUSTRIES: COMPANY OVERVIEW 216 TABLE 178 KEYSTONE INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 216 TABLE 179 CLARBEN LABORATORIES: COMPANY OVERVIEW 217 TABLE 180 CLARBEN LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 218 TABLE 181 HIKMA PHARMACEUTICALS PLC: COMPANY OVERVIEW 219 TABLE 182 HIKMA PHARMACEUTICALS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 220 TABLE 183 ZEYCO: COMPANY OVERVIEW 221 TABLE 184 ZEYCO: PRODUCTS/SERVICES/SOLUTIONS OFFERED 222 TABLE 185 NEW STETIC S.A.: COMPANY OVERVIEW 223 TABLE 186 NEW STETIC S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 224 TABLE 187 CETYLITE, INC.: COMPANY OVERVIEW 225 TABLE 188 CETYLITE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 225 TABLE 189 ICPA HEALTH PRODUCTS LIMITED: COMPANY OVERVIEW 226 TABLE 190 ICPA HEALTH PRODUCTS LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 226 TABLE 191 CENTRIX, INC.: COMPANY OVERVIEW 227 TABLE 192 ZYMETH PHARMACEUTICAL: COMPANY OVERVIEW 228 TABLE 193 DMG AMERICA LLC: COMPANY OVERVIEW 229 TABLE 194 GC SHOWAYAKUHIN CORPORATION: COMPANY OVERVIEW 230 TABLE 195 YOUNG INNOVATIONS, INC.: COMPANY OVERVIEW 231 TABLE 196 CROSSTEX INTERNATIONAL, INC.: COMPANY OVERVIEW 232 TABLE 197 MARK3 (CARGUS INTERNATIONAL, INC.): COMPANY OVERVIEW 233 TABLE 198 J. MORITA CORP.: COMPANY OVERVIEW 234 TABLE 199 KULZER GMBH: COMPANY OVERVIEW 235 TABLE 200 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 236 FIGURE 1 DENTAL ANESTHETICS MARKET SEGMENTATION & REGIONAL SCOPE 24 FIGURE 2 RESEARCH DESIGN 27 FIGURE 3 PRIMARY SOURCES 30 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 32 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 33 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 33 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: SEPTODONT HOLDING 35 FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL ANESTHETICS MARKET (2024) 36 FIGURE 10 BOTTOM-UP APPROACH 36 FIGURE 11 TOP-DOWN APPROACH 37 FIGURE 12 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2025–2030) 38 FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38 FIGURE 14 DATA TRIANGULATION METHODOLOGY 40 FIGURE 15 DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2025 VS. 2030 (USD MILLION) 43 FIGURE 16 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2025 VS. 2030 (USD MILLION) 44 FIGURE 17 DENTAL ANESTHETICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44 FIGURE 18 GEOGRAPHIC SNAPSHOT OF DENTAL ANESTHETICS MARKET 45 FIGURE 19 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET 46 FIGURE 20 INJECTABLE ANESTHETICS SEGMENT IN SOUTH KOREA LED ASIA PACIFIC MARKET IN 2024 47 FIGURE 21 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 48 FIGURE 22 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 48 FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 49 FIGURE 24 DENTAL ANESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 FIGURE 25 UK: PROJECTED NUMBER OF ADULTS (16 YEARS AND OLDER) WITH DENTAL CARIES, 2020–2050 (MILLION) 52 FIGURE 26 DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS 60 FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL ANESTHETICS MARKET (JANUARY 2014–DECEMBER 2024) 74 FIGURE 28 TOP PATENT APPLICANT COUNTRIES FOR DENTAL ANESTHETICS (JANUARY 2014–DECEMBER 2024) 75 FIGURE 29 DENTAL ANESTHETICS MARKET: VALUE CHAIN ANALYSIS 77 FIGURE 30 DENTAL ANESTHETICS MARKET: ECOSYSTEM ANALYSIS 78 FIGURE 31 DENTAL ANESTHETICS MARKET: SUPPLY CHAIN ANALYSIS 79 FIGURE 32 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN DENTAL ANESTHETICS MARKET 82 FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS 82 FIGURE 34 KEY BUYING CRITERIA FOR END USERS 83 FIGURE 35 DENTAL ANESTHETICS MARKET: ADJACENT MARKET ANALYSIS 84 FIGURE 36 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 122 FIGURE 37 EUROPE: DENTAL ANESTHETICS MARKET SNAPSHOT 125 FIGURE 38 NORTH AMERICA: DENTAL ANESTHETICS MARKET SNAPSHOT 141 FIGURE 39 ASIA PACIFIC: DENTAL ANESTHETICS MARKET SNAPSHOT 148 FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL ANESTHETICS MARKET (2024) 178 FIGURE 41 DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 181 FIGURE 42 DENTAL ANESTHETICS MARKET: COMPANY FOOTPRINT 182 FIGURE 43 DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 187 FIGURE 44 EV/EBITDA OF KEY VENDORS 189 FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 189 FIGURE 46 DENTAL ANESTHETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 190 FIGURE 47 DENTSPLY SIRONA: COMPANY SNAPSHOT 199 FIGURE 48 HUONS GLOBAL: COMPANY SNAPSHOT 206 FIGURE 49 HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT 220

同分類最新報告(醫療器材)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們